Ching-Hwa Tsai

1.8k citations
44 papers · 1.5k indexed · h-index 28
Topics
Viral-associated cancers and disorders (37 papers)Cytomegalovirus and herpesvirus research (10 papers)Lymphoma Diagnosis and Treatment (10 papers)
Partner nations
TaiwanUnited StatesJapan

In The Last Decade

Ching-Hwa Tsai

44 papers receiving 1.5k citations

Peers

Ching-Hwa Tsai
Comparison fields: 5 of 96
  • Oncology 1.0k
  • Epidemiology 490
  • Molecular Biology 391
  • Immunology 355
  • Pathology and Forensic Medicine 279
Replace Hufeng Zhou with:
Hufeng Zhou United States
Kong‐Nan Zhao Australia
Esther Larrea Spain
Sören T. Eichhorst Germany
Chia‐Huei Lee Taiwan
Katie Streicher United States
Seiichi Okamura Japan
Deepak Kaul India
Ching-Hwa Tsai relative to Hufeng Zhou United States Hufeng Zhou's profile →
Citations per field
00.5×1.5×2.0×
Hufeng Zhou · 1×
Citations per year

Countries citing papers authored by Ching-Hwa Tsai

Since Specialization
Citations

This map shows the geographic impact of Ching-Hwa Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching-Hwa Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching-Hwa Tsai more than expected).

Fields of papers citing papers by Ching-Hwa Tsai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching-Hwa Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching-Hwa Tsai. The network helps show where Ching-Hwa Tsai may publish in the future.

Co-authorship network of co-authors of Ching-Hwa Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Ching-Hwa Tsai. A scholar is included among the top collaborators of Ching-Hwa Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching-Hwa Tsai. Ching-Hwa Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 47
3 47
4 40
5 2
6 37
7 18
8 28
9 33
10 63
11 40
12 27
13 43
14 31
15 7
16 5
17 32
18 11
19 79
20 4

About Ching-Hwa Tsai

Ching-Hwa Tsai is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine, having authored 44 papers that have together received 1.5k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (37 papers), Cytomegalovirus and herpesvirus research (10 papers) and Lymphoma Diagnosis and Treatment (10 papers). The work is most often cited by research in Oncology (1.0k citations), Immunology (355 citations) and Pathology and Forensic Medicine (279 citations). Ching-Hwa Tsai has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Jen‐Yang Chen, Mei‐Ru Chen, Jean Lu, Yao Chang, Chung‐Pei Lee, Jiin-Tarng Wang, Shaoyin Chen, Sheng‐Yen Huang, Shin-Lian Doong and Chung-Chun Wu. Their work appears in journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026